CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience will participate in a keynote panel at the Therapeutic Area Partnerships conference on November 19, 2013 from 9:00-9:45am. Dr. Dipp will speak alongside Fred Hassan, Partner and Managing Director of Warburg Pincus, and Bernard Davitian, Vice-President and Managing Director of Sanofi-Genzyme BioVentures, on the panel, titled, “Reinventing the BioPharma Ecosystem: Innovation Through Partnerships.”
Help employers find you! Check out all the jobs and post your resume.
